Folic acid and pantothenic acid protection against valproic acid-induced neural tube defects in CD-1 mice

In utero exposure to valproic acid (VPA) during pregnancy is associated with an increased risk of neural tube defects (NTDs). Although the mechanism by which VPA mediates these effects is unknown, VPA-initiated change,, in embryonic protein levels have been implicated. The objectives of this study were to investigate the effect of in utero VPA exposure oil embryonic protein levels of p53. NF-kappa B, Pim-1, c-Myb, Bax, and Bcl-2 in the CD-1 mouse. We also evaluated the protective effects of folic acid and pantothenic acid oil VPA-induced NTDs and VPA-induced embryonic protein changes in this model. Pregnant CD-I mice were administered a teratogenic dose of VPA prior to neural tube closure and embryonic protein levels were analyzed. In our study, VPA (400 mg, kg)-induced NTDs (24(o)(o)) and VPA-exposed embryos with an NTD showed a 2-fold increase in p53. and 4-fold decreases in NF-kappa B, Pim-2. and c-Myb protein levels compared to their phenotypically normal littermates (P < 0.05). Additionally, VPA increased the ratio of embryonic Bax Bcl-2 protein levels ( P < 0.05). Pretreatment of pregnant dams with either folic acid or pantothenic acid prior to VPA significantly protected against VPA-induced NTDs (P < 0.05). Folic acid also reduced VPA-induced alterations in p53, NF-kappa B, Pim-1, c-Myb. and Bax Bcl-2 protein levels, while pantothenic acid prevented VPA-induced alterations in NF-kappa B, Pim-1, and c-Myb. We hypothesize that folic acid and pantothenic acid protect CD-I embryos from VPA-induced NTDs by independent, but not mutually exclusive mechanisms, both of which may be mediated by the prevention of VPA-induced alterations in proteins involved in neurulation. (c) 2005 Elsevier Inc. All rights reserved.